Ascendis Pharma A/S Gains Losses On Change In Fair Value Of Derivatives
Ascendis Pharma A/S (ASND) reported Gains Losses On Change In Fair Value Of Derivatives of -EUR 30.70 million for the 3-month period ending 2022-09-30, per its 6-K filed 2022-11-02.
Discontinued › Income Statement › Other Income
ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives · last filed 2022-11-02
- Ascendis Pharma A/S gains losses on change in fair value of derivatives for the quarter ending 2022-09-30 was -30.70M EUR.
- Ascendis Pharma A/S gains losses on change in fair value of derivatives for the quarter ending 2022-06-30 was 39.30M EUR.
- Ascendis Pharma A/S gains losses on change in fair value of derivatives for the quarter ending 2022-03-31 was 1.10M EUR.
| Period end | Gains Losses On Change In Fair Value Of Derivatives 3 month | Gains Losses On Change In Fair Value Of Derivatives 6 month | Gains Losses On Change In Fair Value Of Derivatives 9 month |
|---|---|---|---|
| 2022-09-30 | -30.70M EUR 6-K · filed 2022-11-02 | 8.60M EUR derived: sum of 2 quarters · filed 2022-11-02 | 9.70M EUR 6-K · filed 2022-11-02 |
| 2022-06-30 | 39.30M EUR 6-K · filed 2022-08-10 | 40.40M EUR 6-K · filed 2022-08-10 | |
| 2022-03-31 | 1.10M EUR 6-K · filed 2022-05-11 |